Luc Mongeau, CEO, discusses focusing on cost reductions and growth in the medical business for short-term success, emphasizing high-potential areas like Canadian REC and medical cannabis in Europe and Australia. The restructuring aims to streamline operations and capitalize on immediate opportunities with high returns.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing